Friday 10 December - Dr Ben Fisher, Senior Lecturer in Clinical Rheumatology, Institute of Inflammation and Ageing and Dr Rowena Sharpe, Director of Precision Medicine Trials, CRCTU, Institute of Cancer and Genomic Sciences (Host: Professor Pam Kearns) “Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19: results from the CATALYST phase 2 proof-of-concept trial”.
Friday 3 December - Professor Abeer Shaaban, Honorary Professor Cancer and Genomic Sciences/ Consultant Pathologist at Queen Elizabeth Hospital Birmingham (Host: Professor Sudha Sundar) "Breast and ovarian cancer in women of ethnic background- What we know so far".
Friday 26 November - Dr Andreas Karwath, Senior Lecturer, Institute of Cancer and Genomic Sciences, University of Birmingham (Host: Dr Roland Arnold) "EHR Representation Learning".
Friday 19 November - Professor Terry Rabbitts, Team Leader, The Institute of Cancer Research, London (Host: Professor Conny Bonifer) "Engineering intracellular antibodies for targeted protein degradation of RAS isoforms or the LMO2 transcription complex".
Friday 12 November - Dr Joana Simoes, General Surgery trainee from Portugal/Research Fellow, NIHR Research Unit on Global Surgery, University of Birmingham (Host: Dr Sovan Sarkar) "Building an international academic career through collaborative research".
Friday 5 November - Professor Alberto Bardelli, University of Turin, Dept. of Oncology and Director of Laboratory Molecular Oncology, Candiolo Cancer Institute, FPO-IRCCS (Host: Dr Chiara Bardella) " High dose Vitamin C and inactivation of DNA repair boost cancer immunotherapy".
Friday 22 October - Dr Viktor Korolchuk, Reader in Molecular Cell Biology, Biosciences Institute, Faculty of Medical Sciences, Newcastle University (Host: Dr Sovan Sarkar) "Nutrient response pathways: molecular mechanisms and physiological functions".
Friday 15 October - Mr Aneel Bhangu, Senior Lecturer in Surgery, University of Birmingham/Consultant Colorectal Surgeon, University Hospital Birmingham (Host: Dr Sovan Sarkar) "The FALCON RCT: A Lancet publication from the NIHR Unit on Global Surgery".
Friday 8 October - Professor Chris Buckley, Director of Clinical Research, Kennedy Institute of Rheumatology, University of Oxford (Host: Dr Fedor Berditchevski) "The implications of the human cell atlas for targeting Fibroblasts in Immune Mediated Inflammatory Diseases".
Friday 1 October - Professor Richard J. Gibbons , Weatherall Institute of Molecular Medicine, University of Oxford (Host: Dr Paloma Garcia) " Understanding a disease of chromatin."
Friday 24 September - Dr Alastair Greystoke, Clinical Senior Lecturer/Hon Consultant, Sir Bobby Robson Clinical Trials Unit Freeman Hospital, Newcastle Upon Tyne (Host: Mr Daniel Slade) "How can we personalise lung cancer treatment? Issues in trial design and delivery."
Friday 10 September - Professor Philip M. Kim, The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Canada (Host: Dr Roland Arnold) - "Integrated development of peptide and protein therapeutics."
Friday 25 June - Professor Dr M. Cristina Cardoso, Chair of Cell Biology and Epigenetics at the Department of Biology of the Technical University of Darmstadt, Germany (Host: Dr Grant Stewart) - “Elementary units of DNA replication and repair: a mirror of chromatin higher order structure?”
Friday 11 June - Professor Syed Hussain, Professor and Honorary Consultant in Medical Oncology, University of Sheffield and Sheffield Teaching Hospitals NHS Trust (Host: Dr Rik Bryan) - “Changing landscape in the management of advanced bladder cancer.”
Friday 4 June - Dr Alexandros Tzatsos, Associate Professor in the Department of Anatomy and Cell Biology and a member of the Cancer Center at the George Washington University School of Medicine in Washington, DC. (Host: Dr Gianmarco Contino) - “Molecular stratification and targeted therapies for pancreatic cancer.”
Friday 28 May - Dr Luke Yates, Research Associate, Department of Infectious Diseases, Imperial College London (Host: Dr Mathew Coleman) - “PIKK-ing apart the DNA damage response: how cryoEM provides a molecular view that rationalises disease mutations and drug design.”
Friday 21 May - Dr Louise Stone, Senior Editor, Nature Reviews Urology (Host: Dr Rik Bryan) - “What editors want – the Nature of Reviews.”
Friday 14 May - Dr Deena Gendoo, Senior Lecturer in Computational Biology, Centre for Computational Biology (Host: Dr Claire Palles) - “Computational pharmacogenomics to identify cancer and subtype-specific therapies.”
Friday 7 May - Dr John Counsell,Senior Research Fellow at the UCL Great Ormond Street Institute of Child Health (Host: Professor Ferenc Mueller) - “Engineering the next generation of genomic medicines.”
Friday 30 April - Prof. Dr. med. Michael Quante,Head of Gastrointestinal Oncology,University of Freiburg, Germany (Host: Dr Claire Palles) - “Lessons from a mouse model of Barrett Esophagus – Translational opportunities in upper GI cancer.”
Friday 23 April - Dr Nicky Whiffin, Sir Henry Dale Fellow and Group Leader, Wellcome Centre for Human Genetics, University of Oxford (Host: Dr Claire Palles) - “Understanding the role of non-coding region variants in rare disease.”
Friday 26 March - Dr Ian Groves, Associate Principal Investigator, Department of Medicine, University of Cambridge (Host: Dr Jo Parish) - “Novel therapeutic strategies to abate human cytomegalovirus-mediated disease in the transplant setting.”
Friday 19 March - Professor Colin Watts, Professor of Neurosurgery, Chair Birmingham Brain Cancer Program (Host: Dr Sovan Sarkar) - “Translating the Science of Gliomas: Current Concepts & Future Challenges.”
Friday 12 March - Professor Esther Moss, Associate Professor in Gynaecological Oncology, University of Leicester (Host: Professor Sudha Sundar) - “Endometrial cancer: The need for personalised treatment.”
Friday 5 March - Professor Jan Jacob Schuringa, Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, The Netherlands (Host: Professor Conny Bonifer) - “Dissecting clonal heterogeneity in AML.”
Friday 26 February - Professor Gerard Graham, Gardiner Chair of Immunology / Head of the Chemokine Research Group / Interim Director of the Institute of Infection, Immunity and Inflammation, University of Glasgow (Host: Dr Elaine Leung) - “Atypical chemokine receptors in biology and pathology.”
Friday 12 February - Dr Kunal Rai, Associate Professor, MD Anderson Cancer Center/Scientific Director, MD Anderson Epigenomics Initiative (Host: Dr Sovan Sarkar) - “Exploiting Cancer Epigenome for Precision Medicine.”
Friday 5 February - Professor Steve Smerdon, Professor of Structural Biology, Institute of Cancer and Genomic Sciences, University of Birmingham (Host: Dr Paloma Garcia/Dr Clare Davies) - “Structural biology at the ICGS: What we are up to and how you can get involved!”
Friday 29 January - Professor Alan Parker, Professor of Translational Virotherapies, Cardiff University (Host: Dr Elaine Leung) - “From basic virology to precision virotherapies: How to train your oncolytic virus.”
Friday 22 January - Professor Marc Peschanski, Director of Research Emeritus at INSERM, Scientific Director of the I-STEM Institute, Scientific Director of the Center for Stem Cell Studies (Host: Professor Timothy Barrett) - “Harnessing pluripotent stem cells for therapies applicable to rare diseases of genetic origin.”
Friday 15 January - Dr Diu Nguyen, Cancer Biology Scientist, Memorial Sloan Kettering Institute, USA (Host: Dr Rui Monteiro) - "Understanding Post-transcriptional Regulation by RNA-Binding Proteins in Normal and Malignant Stem Cells for Novel Therapeutic Opportunities.”